Browse the evidence

Maximal strength shows a significant effect of frequency with an increase in effect size of 0.14 for every day increase in frequency.

Increasing resistance training frequency may lead to greater improvements in maximal strength for older adults.

In females, egg consumption >50 g/d is associated with a 34% lower risk of central obesity.

Encouraging egg consumption in females may help reduce the risk of central obesity.

The nutrition-based shared medical appointment (SMA) intervention resulted in a mean weight loss of 6.6 pounds, while the individualized counseling control group lost a mean of 3.6 pounds.

Practitioners may consider SMA as a more effective approach for weight loss in prediabetic patients.

The intervention resulted in a significant mean weight loss of -4.5 ± 7.2 kg among participants.

Practitioners can consider this intervention as effective for weight loss in similar patient populations.

Approximately 27% of participants lost ≥5% of their initial body weight.

This indicates a notable success rate for significant weight loss in the intervention.

Training increased strength in both age groups (p < 0.05), with no supplementation effect.

Resistance training is effective for increasing strength in both younger and older men.

Type I muscle fibre area increased with training (p = 0.008) with no effect of age or supplementation.

Resistance training effectively increases Type I muscle fibre area regardless of age or supplementation.

The athlete increased horizontal force (F H) in his weak leg by 26% after a targeted training program.

Targeted strength training can effectively increase force production in weaker limbs.

The athlete increased maximal velocity (v max) by 2% and power (P max) by 15% after the training program.

Targeted training can lead to measurable improvements in sprint performance metrics.

Many people can lose weight in the short term by reducing their intake of calories with various diets.

Practitioners can encourage calorie reduction for short-term weight loss.

Participants treated with SAR425899 lost more weight, fat mass, and fat free mass compared to those on placebo (p < 0.05).

SAR425899 may enhance weight loss and body composition improvements.

Semaglutide use is effective in patients with IBD and obesity, resulting in a mean weight loss of over 5%.

Clinicians can consider semaglutide as a viable weight loss option for patients with IBD and obesity.

Postpartum weight gain was the result of increased energy intake after pregnancy rather than decreased energy expenditure.

Women with obesity should be advised on managing energy intake after pregnancy to prevent weight retention.

Women with postpartum weight loss reduced energy intake during the postpartum period by 300 kcal/d.

Encouraging reduced energy intake can aid in postpartum weight loss for women with obesity.

Functional foods rich in bioactive compounds can mitigate oxidative stress and inflammation post-exercise.

Incorporating functional foods into recovery nutrition can enhance recovery by reducing inflammation.

Personalized nutrition informed by genetic and metabolic profiling is a promising approach to tailor recovery strategies.

Tailoring recovery nutrition based on individual profiles can enhance recovery outcomes.

Semaglutide is associated with weight loss in adults.

Practitioners can consider semaglutide as a treatment option for weight loss in adults with type 2 diabetes or obesity.

Semaglutide improves control of diabetes in adults.

Practitioners can utilize semaglutide to enhance diabetes management in adults.

Situational antecedents such as eating in the car and snacking alone were associated with overeating and impulsive eating.

Practitioners should consider environmental factors when addressing overeating behaviors.

Plant-based dietary patterns rich in minimally processed foods, vegetables, and fruits reduce CVD risk.

Health professionals should recommend plant-based diets rich in whole foods to reduce CVD risk.

The Mediterranean, Dietary Approaches to Stop Hypertension, and vegetarian diets reduce CVD risk.

Health professionals should promote these specific dietary patterns to lower CVD risk.

GLP-1 receptor agonists (GLP-1 RA) are a safe and effective treatment for weight regain and insufficient weight loss after metabolic bariatric surgery.

Practitioners can consider GLP-1 RA as a viable option for patients struggling with weight management post-surgery.

Weekly semaglutide leads to significantly greater weight loss compared to daily liraglutide.

Clinicians may prefer semaglutide over liraglutide for enhanced weight loss outcomes.

The push-up is widely used by fitness professionals to develop upper-body strength, power, and local muscular endurance.

Fitness professionals should consider push-ups as a key exercise for upper-body development.